Dadar Maryam, Alamian Saeed, Behrozikhah Ali Mohammad, Yazdani Freshteh, Kalantari Armin, Etemadi Afshar, Whatmore Adrian M
Department of Brucellosis, Razi Vaccine and Serum Research Institute (RVSRI); Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Animal and Plant Health Agency (APHA), Addlestone, Surrey, United Kingdom.
Vet Res Forum. 2019 Fall;10(4):315-321. doi: 10.30466/vrf.2018.89680.2171. Epub 2019 Dec 15.
Brucellosis is a costly contagious disease of human, domestic and wild animals. It is a serious health problem in Iran causing significant economic losses therefore, control approaches to prevent its spread are of great importance. In Iran, the species and biovars of virulent species are still under-reported due to the inadequate diagnostic protocols and insufficient laboratory facilities. The objective of this study was to characterize isolates obtained from passive animal and human surveillance in Iran from 2011 to 2018 in order to understand the current epidemiological situation of the disease. A total of 419 samples (milk, blood, cerebrospinal fluid, abomasum content and aborted fetus tissues) were collected from 65 cases/case series (human and animals) and examined bacteriologically. The initially identified isolates were further characterized using phenotypic and molecular approaches. All recovered isolates were either or . The infection in sheep appeared to be exclusively associated with but both and were common in bovine samples. Samples from one sheep and one goat were confirmed to be infected by the vaccine strain Rev1. In spite of burden in animals (14 cases in cattle and camel), brucellosis in human was predominantly associated with (15 cases). The results confirmed that biovar 1 and biovar 3 remain the most prevalent biovars in Iran. This report builds a picture of the significance of different species in different hosts in Iran and provides applicable information for the healthcare professionals about the public health risks of brucellosis and relevant preventive strategies.
布鲁氏菌病是一种在人类、家畜和野生动物中具有高传播性且代价高昂的疾病。在伊朗,它是一个严重的健康问题,会造成重大经济损失,因此,预防其传播的控制方法至关重要。在伊朗,由于诊断方案不完善和实验室设施不足,强毒株的种类和生物变种仍未得到充分报告。本研究的目的是对2011年至2018年从伊朗被动动物和人类监测中获得的分离株进行特征分析,以了解该疾病目前的流行病学情况。共从65例病例/病例系列(人类和动物)中采集了419份样本(牛奶、血液、脑脊液、皱胃内容物和流产胎儿组织),并进行了细菌学检查。最初鉴定的分离株进一步采用表型和分子方法进行特征分析。所有回收的分离株均为[具体菌株1]或[具体菌株2]。绵羊感染似乎仅与[具体菌株1]有关,但[具体菌株1]和[具体菌株2]在牛样本中都很常见。来自一只绵羊和一只山羊的样本被证实感染了Rev1疫苗株。尽管动物中存在[具体菌株2]感染(牛和骆驼中有14例),但人类布鲁氏菌病主要与[具体菌株1]有关(15例)。结果证实,[具体菌株1]生物变种1和[具体菌株2]生物变种3仍然是伊朗最普遍的生物变种。本报告描绘了伊朗不同宿主中不同[布鲁氏菌]物种的重要性,并为医疗保健专业人员提供了有关布鲁氏菌病公共卫生风险和相关预防策略的适用信息。